|
| Press Releases |
|
 |
|
| Monday, May 23, 2022 |
|
|
医思健康收购连锁体检中心 进一步扩大客户基础整合健康检查市场 |
香港最大非医院医疗服务机构*──医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）欣然宣布，收购美邦医学体检中心及其附属公司（「目标公司」）75%已发行股本，总代价为4,125万港元，将以现金支付。
more info >> |
|
|
醫思健康收購連鎖體檢中心 進一步擴大客戶基礎整合健康檢查市場 |
| 香港最大非醫院醫療服務機構*──醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）欣然宣佈，收購美邦醫學體檢中心及其附屬公司（「目標公司」）75%已發行股本，總代價為4,125萬港元，將以現金支付。 more info >> |
|
|
EC Healthcare Acquires Health Screening Services Chain, Further Expand Customer Base and Consolidate the Health Screening Market |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group acquires 75% of the issued share capital of Mobile Medical International Holdings Limited and its subsidiaries (the "Target Group") for a total consideration of HK$41.25 million in cash. more info >> |
|
| Thursday, April 21, 2022 |
|
|
医思健康料全年销售额超30亿港元 按年增逾35% |
| 香港最大非医院医疗服务机构* ── 医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）欣然公布集团截止2022年3月31日（「年内」）销售额之预期表现。 more info >> |
|
|
醫思健康料全年銷售額超30億港元 按年增逾35% |
| 香港最大非醫院醫療服務機構* ── 醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）欣然公佈集團截止2022年3月31日（「年內」）銷售額之預期表現。 more info >> |
|
|
EC Healthcare expects sales volume to increase 35% Y-o-Y to no less than HK$3 billion for the Year |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the expected performance of the Group's sales volume for the Year ended 31 March 2022 (the "Year"). more info >> |
|
| Thursday, April 7, 2022 |
|
|
医思健康收购兽医业务 进一步整合宠物服务市场 提升市场占有率 |
| 香港最大非医院医疗服务机构* ── 医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）欣然宣布，以现金代价15.75百万港元向一名在香港注册的兽医（「卖方」）收购一家在香港大埔经营兽医医院的目标公司（「目标公司」）75%已发行股本。 more info >> |
|
|
醫思健康收購獸醫業務 進一步整合寵物服務市場 提升市場佔有率 |
| 香港最大非醫院醫療服務機構* ── 醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）欣然宣佈，以現金代價15.75百萬港元向一名在香港註冊的獸醫（「賣方」）收購一家在香港大埔經營獸醫醫院的目標公司（「目標公司」）75%已發行股本。 more info >> |
|
|
EC Healthcare Acquires Veterinary Business, Further Consolidate the Pet Service Industry and Increase Market Shares |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group acquires 75% equity interests in a company operating veterinary hospital in Tai Po (the "Target Companies") from a registered veterinary surgeon in Hong Kong (The "Seller") for a total consideration of HK$15.75 million in cash more info >> |
|
| Monday, April 4, 2022 |
|
|
医思健康新设中环综合医疗服务旗舰中心及太古高端影像中心 |
香港最大非医院医疗服务机构* ── 医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）欣然宣布，集团位于中环的综合医疗服务旗舰中心（「新旗舰中心」）及太古的高端影像中心，分别于2022年3月31日及2022年4月1日正式投入运营，集团在医疗领域的市场份额得以进一步扩大。
more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
珠宝双展匯聚逾82,000环球买家
Mar 9, 2025 13:51 HKT/SGT
|
|
|
珠寶雙展匯聚逾82,000環球買家
Mar 9, 2025 13:41 HKT/SGT
|
|
|
Twin jewellery shows attract over 82,000 global buyers
Mar 9, 2025 13:19 HKT/SGT
|
|
|
OrbusNeich Achieves Fourth Consecutive Year of Revenue Growth with Record High Revenue of US$164.1 Million and Net Profit of US$39.7 Million
Mar 8, 2025 19:40 HKT/SGT
|
|
|
Everest Medicines Hits Three-Year High as AI+mRNA Pipeline Reshapes Valuation
Mar 8, 2025 19:20 HKT/SGT
|
|
|
uSMART Securities Initiates Coverage on NAAS Technology with a 'Buy' Rating and a Target Price of US$3.2 per ADS, Citing Industry Leadership and Profitability Outlook
Mar 7, 2025 21:26: JST
|
|
|
Everest Medicines Hits Three-Year High as AI+mRNA Pipeline Reshapes Valuation
Mar 7, 2025 20:31: JST
|
|
|
uSMART Securities Initiates Coverage on NAAS Technology with a 'Buy' Rating and a Target Price of US$3.2 per ADS, Citing Industry Leadership and Profitability Outlook
Mar 7, 2025 20:26 HKT/SGT
|
|
|
雲頂新耀股價創3年新高 AI+mRNA賦能管線重塑估值
Mar 7, 2025 19:24 HKT/SGT
|
|
|
云顶新耀股价创3年新高 AI+mRNA赋能管线重塑估值
Mar 7, 2025 19:16 HKT/SGT
|
|
|
業聚醫療連續四年實現收入增長 達1.64億美元創新高 純利達3,970萬美元 建議派發末期股息每股10港仙
Mar 7, 2025 18:28 HKT/SGT
|
|
|
业聚医疗连续四年实现收入增长 达1.64亿美元创新高 纯利达3,970万美元 建议派发末期股息每股10港仙
Mar 7, 2025 18:10 HKT/SGT
|
|
|
東信營銷科技：中國AI營銷龍頭斬獲多模態雙備案 技術實力獲國家級認證
Mar 7, 2025 17:58 HKT/SGT
|
|
|
东信营销科技：中国AI营销龙头斩获多模态双备案 技术实力获国家级认证
Mar 7, 2025 17:20 HKT/SGT
|
|
|
Japan's Telecommunications Carriers Enhance Disaster Response with On-site Training for Joint Use of Marine Vessels
Mar 7, 2025 16:24 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
